All pharmaceutical news tagged with ‘Chumakov Center’. Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences.
The Chumakov Center plans to double the production of the CoviVac whole-virion vaccine against the coronavirus to 2.5 mln doses per month in October...
"We have just launched the third phase of clinical trials, therefore, it is too early to talk about the drug’s registration abroad," the Russian expert said.
The Russian Health Ministry has issued a permit to conduct the post-registration clinical trials of the CoviVac shot against the coronavirus infection with the...
The Chumakov Federal Scientific Center intends to double the production of the CoviVac vaccine against the coronavirus infection after it receives new equipment in June-July